Canada & Scotiabank

Canada: Canada>>> is experiencing a technical recession with declining GDP, rising insolvency rates, and increasing unemployment, making it the only G7 nation with a shrinking economy.

Scotiabank: Scotiabank>>>'s chief economist, Derek Holt, dismissed the recession label for Canada>>>, citing temporary factors like harsh winter weather, tariff-induced trade swings, and gold imports as reasons for the GDP decline.

Canada: The Series 19 Preferred Units are offered in all provinces and territories of Canada, and the distribution rate is tied to the 5-year Government of Canada bond yield.

Scotiabank: Scotiabank is a lead underwriter in the offering, facilitating the distribution of the Series 19 Preferred Units to the public.

Canada: Apotex is a Canadian-based company, and its IPO is being conducted through Canadian securities regulatory authorities and listed on a Canadian exchange.

Scotiabank: Scotiabank is a co-lead manager, joint global coordinator, and joint lead bookrunner for Apotex's IPO.

Canada: The offering and the investment portfolio are based in Canada, affecting the Canadian financial market.

Scotiabank: Scotiabank is one of the six publicly traded Canadian banks in which Canadian Banc Corp will invest the net proceeds from its Preferred Share offering.